Q3 2024 · 13F-HR
Eagle Health Investments LPholdings as filed
Filed 2024-11-12 · accession 0001172661-24-004568
$528.0M
Reported value
25
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 632307104 | NTRA | NATERA INC | $54.8M | 10.4% | 431,314 | Common | SOLE |
| 452327109 | ILMN | ILLUMINA INC | $50.5M | 9.57% | 387,354 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $40.7M | 7.70% | 74,990 | Common | SOLE |
| G4705A100 | ICLR | ICON PLC | $37.6M | 7.12% | 130,790 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $37.5M | 7.10% | 513,700 | Common | SOLE |
| 30063P105 | EXK | EXACT SCIENCES CORP | $37.1M | 7.02% | 544,200 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $31.2M | 5.91% | 561,700 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $30.3M | 5.73% | 451,492 | Common | SOLE |
| 91324P102 | UNH | UNITEDHEALTH GROUP INC | $29.6M | 5.61% | 50,700 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $29.5M | 5.58% | 419,212 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $28.8M | 5.46% | 136,603 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $21.0M | 3.97% | 76,256 | Common | SOLE |
| 91307C102 | UTHR | UNITED THERAPEUTICS CORP DEL | $19.4M | 3.67% | 54,099 | Common | SOLE |
| 74276L105 | PRCT | PROCEPT BIOROBOTICS CORP | $18.7M | 3.54% | 233,089 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $14.8M | 2.81% | 128,600 | Common | SOLE |
| 00847X104 | AGIO | AGIOS PHARMACEUTICALS INC | $14.7M | 2.78% | 330,830 | Common | SOLE |
| H17182108 | CRSP | CRISPR THERAPEUTICS AG | $9.3M | 1.75% | 197,000 | PUT | SOLE |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $5.0M | 0.95% | 462,911 | Common | SOLE |
| 516544103 | LNTH | LANTHEUS HLDGS INC | $4.7M | 0.90% | 43,200 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $3.6M | 0.69% | 7,390 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $2.8M | 0.54% | 45,000 | Common | SOLE |
| 89377M109 | TMDX | TRANSMEDICS GROUP INC | $2.8M | 0.54% | 18,061 | Common | SOLE |
| 95075A107 | HOWL | WEREWOLF THERAPEUTICS INC | $1.5M | 0.28% | 700,000 | Common | SOLE |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $1.4M | 0.27% | 46,300 | Common | SOLE |
| 384747101 | GRAL | GRAIL INC | $730,986 | 0.14% | 53,124 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.